/
Innovative Bioresearch Coin (INNBC) by Innovative Bioresearch Ltd. leverages blockchain technology to advance scientific research. Launched in 2018, the project integrates a decentralized science (DeSci) model through its INNBC token, facilitating research funding and ensuring liquidity on decentralized exchanges. The platform also features DApps designed to revolutionize scientific methods. Notably, Innovative Bioresearch Ltd. has published peer-reviewed research findings in renowned journals indexed on PubMed, making it the first crypto project to attain this milestone. INNBC operates on the Ethereum platform, with a total supply of 1,229,840,000,000 tokens, and nearly all in circulation. Currently, the token trades at 0.00000001 USD across 9 markets but has seen minimal recent trading activity.
Innovative Bioresearch Coin (INNBC) by Innovative Bioresearch Ltd. leverages blockchain technology to advance scientific research. Launched in 2018, the project integrates a decentralized science (DeSci) model through its INNBC token, facilitating research funding and ensuring liquidity on decentralized exchanges. The platform also features DApps designed to revolutionize scientific methods. Notably, Innovative Bioresearch Ltd. has published peer-reviewed research findings in renowned journals indexed on PubMed, making it the first crypto project to attain this milestone. INNBC operates on the Ethereum platform, with a total supply of 1,229,840,000,000 tokens, and nearly all in circulation. Currently, the token trades at 0.00000001 USD across 9 markets but has seen minimal recent trading activity.
Innovative Bioresearch Coin (INNBC) is designed to leverage blockchain technology to advance scientific research and drug development. Launched by Innovative Bioresearch Ltd. on the Ethereum platform, INNBC supports decentralized scientific investigations through a decentralized science (DeSci) model, securing research funding and ensuring liquidity on decentralized exchanges.
The INNBC token supports scientific research by providing a platform where drug development efforts are funded through blockchain technology. It uses a decentralized science (DeSci) model to support these activities, allowing for transparent, secure, and efficient funding processes. Additionally, it features decentralized applications (DApps) aimed at revolutionizing scientific methodologies, ensuring studies are published in renowned journals.
INNBC tokens offer a secure and decentralized means for funding scientific research, particularly drug development. By facilitating transactions on decentralized exchanges, the tokens ensure liquidity and financial support without the need for traditional funding bodies. Moreover, this approach allows research findings to be peer-reviewed and published professionally, enhancing credibility in the scientific community.
Unlike other healthcare blockchain projects, Innovative Bioresearch Coin uniquely integrates a decentralized science (DeSci) model directly into its structure, focusing on funding drug development and scientific investigations. Its ability to publish peer-reviewed findings in top journals indexed on PubMed sets it apart as a trailblazer in this sector.
Innovative Bioresearch Coin has reached a unique milestone by being the first crypto project to successfully produce peer-reviewed scientific publications. These findings have been published in renowned journals indexed on PubMed, marking its significance and credibility in merging blockchain technology with the scientific research industry.
Trading Innovative Bioresearch Coin (INNBC) may involve challenges such as low trading volume, as seen with its $0.00 daily trading volume. This can affect liquidity and price stability. To address this, traders should explore increasing their trading on the nine available markets or engage with the community to boost activity. Staying informed about market trends and the project's developments can also help mitigate these issues.
Insight Chain (INB) builds a decentralized research ecosystem with blockchain for secure, transparent data exchange, aiming to revolutionize data utilization and protection.
BCNBCN merges football with blockchain, offering a virtual universe for fan engagement, powered by BCNBCN Tokens for governance, digital collectibles, and exclusive content.
INBlockchain is an investment firm focused on blockchain, incubating companies, providing capital, advisory services, and supporting cryptocurrency investments to fuel the sector's growth.
Brave New Coin specializes in blockchain/data analytics for crypto markets, offering APIs, indices (BLX & ELX), and market insights for traders and institutions.
Oncology Network harnesses blockchain to enhance healthcare in oncology with the ONC token, integrating DeFi principles for secure, seamless transactions.
DeBio Network is a decentralized platform offering anonymous biomedical and biogenetic testing, ensuring data privacy via blockchain, and leveraging its native crypto for transactions.
NeurochainAI provides an all-in-one platform for developing and deploying AI dApps with its consumer-grade GPU DePIN and powerful quantized AI models.
Bnacoin innovates financial markets using AI, blockchain, and quantitative trading, offering a decentralized ecosystem with asset management and cross-chain exchanges. Key components include BNACOIN tokens, a public blockchain, and BNASwap.
Science Blockchain is an incubator leveraging ICOs to fund and support blockchain startups, offering expertise and infrastructure to foster growth in various sectors.
INRx (INRX) is a cryptocurrency launched in 2022 on the Ethereum platform, aiming to provide a stable digital asset for transactions and DeFi activities.
SciNet transforms science using blockchain and AI, enhancing collaboration, transparency, and fair rewards.
Blockchain platform supporting green economy and sustainable development.
